ASSOCIATION OF GLP-1 AGONISTS WITH ARRHYTHMIAS AND SUDDEN CARDIAC DEATH IN PATIENTS WITH TYPE 2 DIABETES: A META-ANALYSIS OF 27 RANDOMIZED CONTROLLED TRIALS

被引：0
|
作者：
Al-Sadawi, Mohammed [1 ]
Aslam, Faisal [1 ]
Aleem, Saadat [1 ]
Alsadaoee, Maryam [1 ]
Stevens, Gregg Alexander [1 ]
Singh, Abhijeet [1 ]
Almasry, Ibrahim O. [1 ]
Rashba, Eric J. [1 ]
Fan, Roger [1 ]
机构：
[1] Stony Brook Med, Stony Brook, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2022年 / 79卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1525 / 1525
页数：1
相关论文
共 50 条
  • [31] GLP-1 Receptor Agonists and Cardiovascular Disease: a Meta-Analysis of Recent Cardiac Outcome Trials
    Jia, Xiaoming
    Alam, Mahboob
    Ye, Yumei
    Bajaj, Mandeep
    Birnbaum, Yochai
    CARDIOVASCULAR DRUGS AND THERAPY, 2018, 32 (01) : 65 - 72
  • [32] GLP-1 Receptor Agonists and Cardiovascular Disease: a Meta-Analysis of Recent Cardiac Outcome Trials
    Xiaoming Jia
    Mahboob Alam
    Yumei Ye
    Mandeep Bajaj
    Yochai Birnbaum
    Cardiovascular Drugs and Therapy, 2018, 32 : 65 - 72
  • [33] The relationship between the use of GLP-1 receptor agonists and the incidence of respiratory illness: a meta-analysis of randomized controlled trials
    Yu, Meixin
    Wang, Ruxin
    Pei, Ling
    Zhang, Xiaofang
    Wei, Jinjing
    Wen, Yun
    Liu, Han
    Ye, Haowen
    Wang, Jinghao
    Wang, Lihong
    DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
  • [34] The relationship between the use of GLP-1 receptor agonists and the incidence of respiratory illness: a meta-analysis of randomized controlled trials
    Meixin Yu
    Ruxin Wang
    Ling Pei
    Xiaofang Zhang
    Jinjing Wei
    Yun Wen
    Han Liu
    Haowen Ye
    Jinghao Wang
    Lihong Wang
    Diabetology & Metabolic Syndrome, 15
  • [35] Efficacy and safety of GLP-1 agonists in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials
    Messak, Mark
    Abdelmageed, Ahmed
    Senbel, Abdelrahman A.
    Khattab, Youssef A.
    Mandour, Youssef
    Shaker, Omar
    Rehan, Ahmed Hamed
    Oransa, Samir
    Nasr, Mohamed
    Shabeeb, Abdullah Emad
    Rezq, Ziyad
    Hossam, Fares
    Abouelmagd, Moaz Elsayed
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025,
  • [36] Association between sodium-glucose cotransporter-2 inhibitors and risk of sudden cardiac death or ventricular arrhythmias: a meta-analysis of randomized controlled trials
    Sfairopoulos, Dimitrios
    Zhang, Nan
    Wang, Yueying
    Chen, Ziliang
    Letsas, Konstantinos P.
    Tse, Gary
    Li, Guangping
    Lip, Gregory Y. H.
    Liu, Tong
    Korantzopoulos, Panagiotis
    EUROPACE, 2022, 24 (01): : 20 - +
  • [37] Effect of sacubitril/valsartan on the occurrence of cardiac arrhythmias and the risk of sudden cardiac death in heart failure: A meta-analysis of randomized controlled trials
    Liu, Xue-Hui
    Wang, Guan-Ling
    Xu, Qiang
    Zhang, Lei
    Liu, Hong-Jun
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [38] Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
    Kristensen, Soren L.
    Rorth, Rasmus
    Jhund, Pardeep S.
    Docherty, Kieran F.
    Sattar, Naveed
    Preiss, David
    Kober, Lars
    Petrie, Mark C.
    McMurray, John J. V.
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (10): : 776 - 785
  • [39] Safety and tolerability of GLP-1 receptor agonists in patients with type 2 diabetes in comparator-controlled DURATION trials
    MacConell, L.
    Chen, S.
    Gurney, K.
    Malloy, J.
    Zhang, H.
    Zhou, M.
    Kolterman, O.
    DIABETOLOGIA, 2012, 55 : S329 - S329
  • [40] Acute pancreatitis associated with GLP-1 Agonists (Exenatide and Liraglutide) exposure: a meta-analysis of published randomized controlled clinical trials
    Alves, Carlos
    Batel-Marques, Francisco
    PHARMACOTHERAPY, 2012, 32 (05): : E113 - E113
12345